Suvretta Capital Management LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 9.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 146,845 shares of the healthcare conglomerate’s stock after selling 14,623 shares during the period. UnitedHealth Group accounts for 2.7% of Suvretta Capital Management LLC’s holdings, making the stock its 7th biggest position. Suvretta Capital Management LLC’s holdings in UnitedHealth Group were worth $85,857,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Quent Capital LLC lifted its holdings in UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after purchasing an additional 217 shares in the last quarter. Railway Pension Investments Ltd lifted its holdings in UnitedHealth Group by 1.0% during the first quarter. Railway Pension Investments Ltd now owns 265,520 shares of the healthcare conglomerate’s stock valued at $131,353,000 after purchasing an additional 2,500 shares in the last quarter. Cypress Asset Management Inc. TX lifted its holdings in UnitedHealth Group by 1.1% during the first quarter. Cypress Asset Management Inc. TX now owns 10,118 shares of the healthcare conglomerate’s stock valued at $5,089,000 after purchasing an additional 114 shares in the last quarter. American Trust lifted its holdings in UnitedHealth Group by 4.5% during the first quarter. American Trust now owns 17,474 shares of the healthcare conglomerate’s stock valued at $8,644,000 after purchasing an additional 749 shares in the last quarter. Finally, Jackson Wealth Management LLC raised its position in shares of UnitedHealth Group by 4.7% in the first quarter. Jackson Wealth Management LLC now owns 15,822 shares of the healthcare conglomerate’s stock valued at $7,827,000 after buying an additional 714 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Trading Up 0.3 %
NYSE UNH opened at $608.38 on Friday. The firm has a 50 day simple moving average of $584.72 and a 200-day simple moving average of $555.39. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a market cap of $559.88 billion, a price-to-earnings ratio of 39.63, a PEG ratio of 1.79 and a beta of 0.58.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.38%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.
Analyst Ratings Changes
A number of equities research analysts have recently commented on UNH shares. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, November 20th. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. KeyCorp began coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective for the company. Finally, Barclays raised their price objective on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research report on Wednesday. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $618.26.
Get Our Latest Research Report on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- How to Choose Top Rated Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Upcoming IPO Stock Lockup Period, Explained
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 3 REITs to Buy and Hold for the Long Term
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.